BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25246406)

  • 1. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli.
    Vervoort J; Xavier BB; Stewardson A; Coenen S; Godycki-Cwirko M; Adriaenssens N; Kowalczyk A; Lammens C; Harbarth S; Goossens H; Malhotra-Kumar S
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7225-33. PubMed ID: 25246406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in chromosomal genes
    Wan Y; Mills E; Leung RCY; Vieira A; Zhi X; Croucher NJ; Woodford N; Jauneikaite E; Ellington MJ; Sriskandan S
    Microb Genom; 2021 Dec; 7(12):. PubMed ID: 34860151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-Mediated OqxAB Is an Important Mechanism for Nitrofurantoin Resistance in Escherichia coli.
    Ho PL; Ng KY; Lo WU; Law PY; Lai EL; Wang Y; Chow KH
    Antimicrob Agents Chemother; 2016 Jan; 60(1):537-43. PubMed ID: 26552976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates.
    Zhang X; Zhang Y; Wang F; Wang C; Chen L; Liu H; Lu H; Wen H; Zhou T
    Int J Antimicrob Agents; 2018 Aug; 52(2):226-232. PubMed ID: 29753133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology and nitrofurantoin resistance determinants of nitrofurantoin-non-susceptible Escherichia coli isolated from urinary tract infections.
    Mottaghizadeh F; Mohajjel Shoja H; Haeili M; Darban-Sarokhalil D
    J Glob Antimicrob Resist; 2020 Jun; 21():335-339. PubMed ID: 31627025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of nitrofurantoin resistance among Enterobacteriaceae and mutational landscape of in vitro selected resistant Escherichia coli.
    Khamari B; Adak S; Chanakya PP; Lama M; Peketi ASK; Gurung SA; Chettri S; Kumar P; Bulagonda EP
    Res Microbiol; 2022; 173(1-2):103889. PubMed ID: 34718096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Genetic Bases of Nitrofurantoin Resistance in Clinical Isolates of Two Successful Multidrug-Resistant Clones of Salmonella enterica Serovar Typhimurium: Pandemic "DT 104" and pUO-StVR2.
    García V; Montero I; Bances M; Rodicio R; Rodicio MR
    Microb Drug Resist; 2017 Jun; 23(4):405-412. PubMed ID: 27809653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
    J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli.
    Whiteway J; Koziarz P; Veall J; Sandhu N; Kumar P; Hoecher B; Lambert IB
    J Bacteriol; 1998 Nov; 180(21):5529-39. PubMed ID: 9791100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IS
    Wan Y; Sabnis A; Mumin Z; Potterill I; Jauneikaite E; Brown CS; Ellington MJ; Edwards A; Sriskandan S
    Microb Genom; 2023 Sep; 9(9):. PubMed ID: 37672334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving nitrofurantoin resistance prediction in
    Dulyayangkul P; Sealey JE; Lee WWY; Satapoomin N; Reding C; Heesom KJ; Williams PB; Avison MB
    Antimicrob Agents Chemother; 2024 May; ():e0024224. PubMed ID: 38767379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli.
    Le VVH; Davies IG; Moon CD; Wheeler D; Biggs PJ; Rakonjac J
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of major Escherichia coli reductases involved in aerobic nitro and azo reduction.
    Mercier C; Chalansonnet V; Orenga S; Gilbert C
    J Appl Microbiol; 2013 Oct; 115(4):1012-22. PubMed ID: 23795903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmidic Fluoroquinolone Resistance Genes in Fluoroquinolone-Resistant and/or Extended Spectrum Beta-Lactamase-Producing
    Akgoz M; Akman I; Ates AB; Celik C; Keskin B; Ozmen Capin BB; Karahan ZC
    Microb Drug Resist; 2020 Nov; 26(11):1334-1341. PubMed ID: 32407158
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploring the in situ evolution of nitrofurantoin resistance in clinically derived uropathogenic Escherichia coli isolates.
    Vallée M; Harding C; Hall J; Aldridge PD; Tan A
    J Antimicrob Chemother; 2023 Feb; 78(2):373-379. PubMed ID: 36480295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete Genome Sequences of Nitrofurantoin-Sensitive and -Resistant Escherichia coli ST540 and ST2747 Strains.
    Xavier BB; Vervoort J; Stewardson A; Adriaenssens N; Coenen S; Harbarth S; Goossens H; Malhotra-Kumar S
    Genome Announc; 2014 Apr; 2(2):. PubMed ID: 24723707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the role played by NfsA, NfsB nitroreductase and NemA flavin reductase from Escherichia coli in the conversion of ethyl 2-(2'-nitrophenoxy)acetate to 4-hydroxy-(2H)-1,4-benzoxazin-3(4H)-one (D-DIBOA), a benzohydroxamic acid with interesting biological properties.
    Valle A; Le Borgne S; Bolívar J; Cabrera G; Cantero D
    Appl Microbiol Biotechnol; 2012 Apr; 94(1):163-71. PubMed ID: 22173483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structures of E. coli NfsA bound to the antibiotic nitrofurantoin; to 1,4-benzoquinone and to FMN.
    Day MA; Jarrom D; Christofferson AJ; Graziano AE; Anderson JLR; Searle PF; Hyde EI; White SA
    Biochem J; 2021 Jul; 478(13):2601-2617. PubMed ID: 34142705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antibacterial activity of nitrofurantoin against clinical isolates of E. coli in Japan and evaluation of biological cost of nitrofurantoin resistant strains using a mouse urinary tract infection model.
    Nakagawa S; Kurimoto Y; Ezumi M; Nakatani K; Mizunaga S; Yamagishi Y; Mikamo H
    J Infect Chemother; 2021 Feb; 27(2):250-255. PubMed ID: 33060044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.